Skip to main content
Clinical Trials/NCT05941013
NCT05941013
Recruiting
Not Applicable

Ultrasound-detectable Endotracheal Tube: a Feasibility Study

John R. Charpie1 site in 1 country20 target enrollmentNovember 15, 2023

Overview

Phase
Not Applicable
Intervention
Ultrasound detectable cuffed endotracheal tube (USD-ETT)
Conditions
Cardiac Catheterization
Sponsor
John R. Charpie
Enrollment
20
Locations
1
Primary Endpoint
Proportion of the USD-ETTs visualized by ultrasound
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

The researchers are studying whether special features make it easier to see if the breathing tube is in the correct place. It is hoped that the investigational device will enable more accurate placement (depth and trachea vs. esophagus).

Detailed Description

The participant will have a breathing tube where the balloon (cuff) at the end of the tube has two special features: 1) The balloon will have a divot in it, rather than be round in shape, and 2) The balloon will be filled with saline (salt water), rather than air. The breathing tube is called an ultrasound detectable cuffed endotracheal tube (USD-ETT). The USD-ETT has not been tested or used in humans previously.

Registry
clinicaltrials.gov
Start Date
November 15, 2023
End Date
April 1, 2027
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
John R. Charpie
Responsible Party
Sponsor Investigator
Principal Investigator

John R. Charpie

Professor of Pediatric Cardiology, Professor of Pediatrics

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Patient is undergoing scheduled or planned diagnostic or interventional cardiac catheterization with planned general anesthesia requiring endotracheal intubation.

Exclusion Criteria

  • Patient has a known airway abnormality, including tracheal stenosis, previous tracheal stenosis, or tracheobronchomalacia.
  • Patient has a tracheostomy.
  • Patient is ventilator-dependent.
  • Patient has an anticipated difficult intubation based upon airway exam and/or history of difficult intubation.
  • Patient is unlikely (in opinion of anesthesia team) or is unable to be intubated with 3.5 mm, 4.0 mm, or 4.5 mm Inner Diameter USD-ETT due to the size of the patient or their airway.
  • Patient is already intubated prior to the scheduled procedure.
  • It is anticipated that the patient will not be extubated after the catheterization procedure.
  • Concurrent enrollment in another clinical trial with an intervention during the cardiac catheterization procedure or 30 days afterwards.
  • Allergy to plastic/materials in USD-ETT

Arms & Interventions

Ultrasound detectable cuffed endotracheal tube (USD-ETT)

Intubation with a novel ultrasound-detectable endotracheal tube

Intervention: Ultrasound detectable cuffed endotracheal tube (USD-ETT)

Outcomes

Primary Outcomes

Proportion of the USD-ETTs visualized by ultrasound

Time Frame: Within 5 minutes of placing the ultrasound probe at the suprasternal notch after intubation

Reported as a 'yes' or 'no' - this outcome simply seeks to verify if the ultrasound can detect the ultrasound detectable cuffed endotracheal tube. The outcome measure assesses if the device is detectable as designed. It does not assess health related information.

Secondary Outcomes

  • Safely support ventilation and oxygenation of the patient during the procedure(Immediately following extubation)
  • Kappa agreement between placement location of USD-ETT as assessed by ultrasound and fluoroscopy(Approximately 5 minutes after of placing the ultrasound probe at the suprasternal notch after intubation)
  • Adverse events that could be related to the USD-ETT device(Up to 30 days post intubation)

Study Sites (1)

Loading locations...

Similar Trials